Latest Articles
August 7, 2025
Scaling Early Detection and Prevention: 5 Lessons from HCA Healthcare
Recap of a recent Becker’s Healthcare podcast with Dr. Dax Kurbegov, who shared how his team is building a scalable model for risk assessment and…
BRCA1 & 2
Cancer Risk
Genetic Testing
Hereditary Cancer
August 5, 2025
The Gene Scene: TGFBR1
This installment of the Gene Scene covers TGFBR1-related Loeys-Dietz Syndrome.
Gene Mutation
Gene Scene
Genetic Counselors
July 21, 2025
The Gene Scene: PCSK9
This installment of the Gene Scene explores PCSK9 variants.
Gene Mutation
Gene Scene
Genetic Counselors
Genetic Testing
July 16, 2025
Creating Program Champions: The Power of Staff Education and Ownership in Our High-Risk Women’s Program
Lisa McGuire discusses the importance of the Ambry CARE Program in launching a High-Risk Women’s Program at HCA Florida Ocala
Breast Cancer
OBGYN
July 16, 2025
The Gene Scene: VHL
Each week, we explore a gene from the ACMG Secondary Findings list—genes identified as having clear, actionable health implications. These genes are included because they’re…
Gene Mutation
Gene Scene
June 26, 2025
Building Trust in Digital Screening: Validating CARE’s Hereditary Cancer Risk Assessment
Rob Pilarski shares validation results for Ambry’s CARE Program® (CARE), recently published in the Journal of the National Comprehensive Cancer Network.
Breast Cancer
Genetic Testing
NCCN
Ovarian Cancer
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)